Midori Nakagaki

6PUBLICATIONS
7CO-AUTHORS
Te oranga ā-pāpori, ā-hinengaro, ā-ahurea, ā-wairua o te Māori (Māori social, cultural, emotional and spiritual wellbeing)Haematological tumoursOral and maxillofacial surgeryRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 03, 2026
Oral mucositis management in hematopoietic cell transplantation in Australia and New Zealand (CAN EAT Survey).

Emma Munro, Nicole C Gavin, Midori Nakagaki

|Dec 19, 2023
A randomised trial of topical polaprezinc to prevent oral mucositis in patients undergoing haematopoietic stem cell transplantation (ToPaZ study).

Midori Nakagaki, Glen A Kennedy, Nicole C Gavin

|Aug 25, 2022
The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.

Midori Nakagaki, Glen A Kennedy, Nicole C Gavin

|Nov 25, 2021
A real-world accuracy of oral mucositis grading in patients undergoing hematopoietic stem cell transplantation.

Midori Nakagaki, Nicole C Gavin, Alexandra Clavarino

|Aug 07, 2021
Implementation and evaluation of a nurse-allied health clinic for patients after haematopoietic stem cell transplantation.

Midori Nakagaki, Nicole C Gavin, Therese Hayes

|Oct 15, 2016
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.

Midori Nakagaki, Michael Barras, Cameron Curley

Pageof 1